The bar chart shows information about how much money was spenton research by five popular pharmaceutical companies in 2012 to 2022. Overall, all the figures showed increase over the period. Moreover, Novas stood out among other companies and showed the highest figure.
Novas and Fleming exhibited higher figures compared to remeining ones. Starting at 3 milions in 2012, the amount of money spent on research in Novas grew to 17 millions in 2018. The figure continued it’s trajectory and reached 57 millions in the final year. Fleming spent 5 millions in the first year, but then the figure rose significantly over the period and reached 30 millions in 2022.
Biopharm, Avicenna and Pharm followed similiar patterns. In the first year Biopharm didn’t spent money on research but there was an increase to 6 millions in the 2018. In the final year the figure reached 24 millions. The amount of money spent by Avicenna started at 2 millions, the figure that then increased to 23 millions in the final year. Pharm spent 9 millions in 2012 but in the next yearthe amount of money grew to 12 millions. In the final year the figure reached 22 millions.
